Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Christopher Bibb

Anatomic Pathology & Clinical Pathology Bryan, TX Medical Doctor

NPI 1992917272 CMS profile 1188692

2801 Franciscan Dr, St. Joseph Regional Medical Center, Pathology Dept., Bryan, TX 77802

Open in the dashboard

General payments

$1,121,877

1,353 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Christopher Bibb of Bryan, TX is reported in the CMS Open Payments database as having received $1,121,877 across 1,353 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Anatomic Pathology & Clinical Pathology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $225,172 302
2024 General $221,889 297
2023 General $206,257 272
2022 General $176,274 220
2021 General $162,979 165
2020 General $104,374 83
2019 General $24,932 14

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Christopher Bibb
  • Anatomic Pathology & Clinical Pathology median
  • Middle half of Anatomic Pathology & Clinical Pathology
  • National median

In program year 2025, general payments to Christopher Bibb were reported at $225,172. Among 2,804 Anatomic Pathology & Clinical Pathology profiles paid that year, the median was $51 and the middle half received between $24 and $149.

Show as a table
Year Christopher Bibb Anatomic Pathology & Clinical Pathology median Middle half National median
2019 $24,932 $65 $22–$150 $163
2020 $104,374 $44 $19–$144 $114
2021 $162,979 $42 $19–$142 $132
2022 $176,274 $54 $20–$140 $149
2023 $206,257 $60 $23–$157 $160
2024 $221,889 $51 $23–$145 $164
2025 $225,172 $51 $24–$149 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. CSL Plasma Inc. $653,005 867 payments
  2. CSL Behring $403,540 448 payments
  3. Takeda Pharmaceuticals U.S.A., Inc. $40,069 19 payments
  4. Shire North American Group Inc $24,877 12 payments
  5. Inspire Medical Systems, Inc. $277 3 payments
  6. Fisher Scientific Company L.L.C. $55 2 payments
  7. Agilent Technologies, Inc. $36 1 payment
  8. Myriad Genetic Laboratories, Inc. $17 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $1,121,153 1,345 payments
  2. Food and Beverage $385 7 payments
  3. Travel and Lodging $338 1 payment
Products named General payments · program years 2019–2025
  1. INSPIRE $277 3 payments
  2. Procalcitonin $55 2 payments
  3. BRAC CDx $17 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 11 billing codes

Paid by Medicare

$82,545

Medicare's payments for the services billed

Medicare patients

469

Average age 71

Services billed

3,027

252 women, 217 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 42%
Diabetes 32%
Ischemic heart disease 25%
Cancer 19%
Depression 18%
Chronic kidney disease 17%
Osteoporosis 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

1,353 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Anatomic Pathology & Clinical Pathology in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record